Zydus Cadila India - Search Videos

CEO of Indian Pharmaceutical giant Zydus Cadila, Pankaj Patel informed that industry has produced 20 crore Hydroxychloroquine tablets which are in high demand worldwide amid COVID-19 outbreak. “Pharmaceutical industry has significantly increased the production of hydroxychloroquine (HCQ). 20 crore tablets of HCQ have been produced by the industry this month,” said Pankaj Patel, CEO of Zydus Cadila, in Ahmedabad. | The Times of India

CEO of Indian Pharmaceutical giant Zydus Cadila, Pankaj Patel informed that industry has produced 20 crore Hydroxychloroquine tablets which are in high demand worldwide amid COVID-19 outbreak. “Pharmaceutical industry has significantly increased the production of hydroxychloroquine (HCQ). 20 crore tablets of HCQ have been produced by the industry this month,” said Pankaj Patel, CEO of Zydus Cadila, in Ahmedabad. | The Times of India

17.7K viewsApr 11, 2020

FacebookThe Times of India

Zydus Cadila Q4 | Ebitda Above Estimates

Zydus Cadila Q4 | Ebitda Above Estimates

timesnownews.comPankaj Poddar

Zydus Cadila's Covid Vaccine For Children In India In Two Weeks

Zydus Cadila's Covid Vaccine For Children In India In Two Weeks

Zydus Cadila seeks Emergency Use Authorisation for its Covid-19 vaccine ZyCoV-D in India

Zydus Cadila seeks Emergency Use Authorisation for its Covid-19 vaccine ZyCoV-D in India

జైడస్ క్యాడిలా ఒక్క డోసు ధర రూ. 265: కోటి డోసులు ఆర్డర్ చేసిన భారత్

జైడస్ క్యాడిలా ఒక్క డోసు ధర రూ. 265: కోటి డోసులు ఆర్డర్ చేసిన భారత్

Zydus Cadila COVID-19 vaccine to be available soon for 12-18 age group: Centre

Zydus Cadila COVID-19 vaccine to be available soon for 12-18 age group: Centre

Covid 360: Everything you need to know about Zydus Cadila's three-dose vaccine

Covid 360: Everything you need to know about Zydus Cadila's three-dose vaccine

India TodayIndia Today Television

Zydus Cadila seeks emergency use approval for COVID vaccine for 12 years old and above

Zydus Cadila plans to complete late-stage trials for its candidate for the novel coronavirus vaccine by February or March. It could produce up to 100 million doses a year initially if it is successful, according to the company chairman on Friday. Cadila’s vaccine candidate, known as ZyCov-D, is one of dozens being developed around the world to fight the coronavirus pandemic. | The Times of India

23.8K viewsJul 18, 2020

FacebookThe Times of India

Govt panel recommends emergency use authorisation to Zydus Cadila's 3-dose Covid vaccine

Why AIIMS Chief Thinks Zydus Cadila DNA Vaccine Is A Boost For India | NDTV

32.2K viewsAug 21, 2021

Zydus Cadila begins enrolment for Phase 3 vaccine trial: Reports

India approves Zydus Cadila's DNA based Covid vaccine for emergency use

India TodayIndia Today TV

Zydus Cadila's ZyCov-D: All About World’s First DNA Vaccine For Covid | 10 Points

Zydus To Produce 1 Crore Doses Per Month By October, Says Chief

Zydus Cadila gets approval for emergency use; authorization from the drug controller general of India

timesnownews.com

Vaaccine Update: Zydus Cadila ZyCoV-D is Okayed for Children

timesnownews.com

Zydus Cadila likely to seek nod for emergency use of Covid vaccine candidate this month | Exclusive Interview

India TodayIndia Today Television

Zydus Cadila's Covid-19 vaccine to be administered in 7 states first: Govt sources

India TodayIndia Today Television

Zydus Cadila to seek emergency use nod for its Covid vaccine ZyCoV-D in 7-10 days: Sources

India TodayIndia Today Television

Zydus Cadila gets tentative nod from US health regulator to market type-2 diabetes drug

Zydus Cadila Needle-Free Covid Vaccine Rollout Next Month: Company Chief

Zydus Cadila seeks emergency use nod for ZyCoV D; targets 1 crore vaccines a month - BusinessToday

businesstoday.in

All About Zydus Cadila's Needle-Free COVID-19 Vaccine: Explained

Zydus Cadila’s two-dose vaccine candidate has been cleared by DGCA for phase 3 clinical trial in India. Once approved, this will boost the vaccination drive in the country. | The Times of India

2.5K viewsOct 5, 2021

FacebookThe Times of India

Zydus | Success Story of India's 4th biggest pharma company

startuptalky.com

India approves Zydus Cadila's DNA based COVID-19 vaccine for emergency use https://bit.ly/381Z6g2 | The Economic Times

1.1K viewsAug 20, 2021

FacebookThe Economic Times

Need To Do Lot More To Overcome Delta Strain, Says Cadila MD

PM Modi reaches Zydus Cadila's plant to review COVID-19 vaccine development Track #Covid19 latest updates here https://bit.ly/2Vbt8ri | The Economic Times

36.9K viewsNov 28, 2020

FacebookThe Economic Times

Zydus Cadila: India approves world's first DNA Covid vaccine

BBCSoutik Biswas

See more